Navigation Links
Pfizer unveils anti-smoking drug

Pfizer's new drug was inspired by a natural remedy tested by doctors in the Soviet Union in the late 1960s. The Soviet doctors had tested a chemical called cytisine, derived from a weed sometimes called false tobacco, as a pill to help smokers kick the habit. They reported that cytisine partially activated the nicotine receptors in the brain without being addictive.
Pfizer Inc. unveiled an experimental drug to help people quit smoking //that could become the drugmaker's next blockbuster.

In clinical trials involving several hundred smokers, the New York-based company said almost half of smokers given this oral medicine, called Varenicline, were able to quit smoking after only seven weeks.

In the same trial, only 16 percent of people receiving sugar pills managed to stop, while 33 percent of patients who received Zyban, a pill sold as Wellbutrin for depression, were able to quit.

"This is a significant improvement over results achieved with Zyban, an antidepressant approved as an aid to smoking cessation." Side effects of the Pfizer drug appeared negligible so far, and the drug has "an excellent safety profile," said Pfizer's spokeswoman.

Varenicline is currently in the final phase of widespread human clinical trials, but there's no timeline for when the anti-smoking drug might hit the market.

The company, however, cautioned that the results of its big clinical studies will take time, and a positive outcome isn't always guaranteed. Pfizer said it is unclear how long patients need to be on Varenicline after quitting.
'"/>




Page: 1

Related medicine news :

1. The Effectiveness Of The Breast Cancer Drug By Pfizer
2. New Drug Exubera (Oral Inhaled Insulin) To Be Monitored By Pfizer
3. Erectile Dysfunction Drug Viagra Launched In India By Pfizer
4. Pfizer’s Eraxis Approved By The FD
5. Pfizer Launches Viagra For Lung Disease In UK
6. Pfizer Acquires Worldwide Rights For New Overactive Bladder Drug
7. Pfizer Commences Its Advertising for Celebrex with All the Warnings
8. FDA Approves Pfizer’s Anti-smoking Dru
9. Pfizer vouches safety of long-term inhaled insulin.
10. NICE Setback Rules for Pfizers Inhaled Insulin
11. Patency On Two Drugs From Merck & Pfizer’s To Expire Soo
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/20/2017)... ... January 20, 2017 , ... A new partnership between ... they no longer use or need, from clothes to couches to dressers and bicycles. ... and take them to the nearest Goodwill donation center through February 28th. , ...
(Date:1/20/2017)... Miami, Florida (PRWEB) , ... January 20, 2017 , ... ... in head lice cases in families with school-aged children since the holiday season. ... spend the holidays with their families, sharing hugs and taking photos, which is the ...
(Date:1/20/2017)... ... January 20, 2017 , ... ... its sugar-free alternative VW+ 002. The drinks have been produced in collaboration with ... to perform during your workout. , After a successful launch in Sweden last ...
(Date:1/20/2017)... ... 2017 , ... D R Burton Healthcare Products LLC, makers ... in a study indicating superior performance against competitive products in secretion clearance. ... Positive Expiratory Pressure Devices During Simulated Breathing“ was published in the winter issue ...
(Date:1/20/2017)... ... January 20, 2017 , ... “God's Miracle Man: Against All Odds”: an ... of published author, Keith C. A. Tucker, son of Minister Delores Pinnock and a ... by Reverend Mark Hardy , “While sitting up in bed, I felt a pounding ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 19, 2017 Shire plc (LSE: ... U.S. Food and Drug Administration (FDA) has acknowledged receipt ... Application (NDA) for SHP465, a long-acting, triple-bead, mixed amphetamine ... once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA is ... 20, 2017, the designated Prescription Drug User Fee Act ...
(Date:1/19/2017)... 19, 2017 Pfizer joins ... Milner Therapeutics Consortium   Major research ... Cambridge   The Milner Therapeutics ... ) as a partner to the Milner Therapeutics Consortium. ... the efficient transfer of materials between industry and academia ...
(Date:1/19/2017)... Florida , January 19, 2017 ... Trump administration appears serious about reducing the FDA,s ... and innovation in the medical drug industry, many ... ahead with new clinical trials and development of ... companies forging ahead with recent developments include:  Moleculin ...
Breaking Medicine Technology: